Ads
related to: merck pharmaceuticals- Dosage and Administration
Find Dosage Info & More
at the Official HCP Site.
- Clinical Trial Data
Find Efficacy Information
About M-M-R® II at the HCP Site.
- FAQs Information
Find Common Questions and Answers
Visit the Official HCP Site.
- Storage and Handling
HCPs Can Find Storage Info
& More for M-M-R® II Here.
- Dosage and Administration
Search results
Merck is spending $3 billion on an eye drug developer as it braces to lose a key cancer patent
Quartz· 2 days agoPharma giant Merck said on Wednesday that it is acquiring the privately-held eye drug developer...
Merck introduces sterility testing solution for pharma quality control
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe latest development comes after Merck announced an investment of more than €300m ($320.8m) in a...
Is Merck & Co., Inc. (NYSE:MRK) the Best Dow Stock To Buy According to Hedge Funds?
Insider Monkey via Yahoo Finance· 6 days agoWe recently identified the best dow stocks according to hedge funds. Even though Merck & Co., Inc....
Unveiling Merck (MRK)'s Value: Is It Really Priced Right? A Comp
Guru Focus· 3 days agoMerck & Co Inc (MRK, Financial) recently experienced a daily loss of 2.46%, contributing to a three-month decline of 0.74%. With an Earnings Per Share (EPS) of 0.9, the question ...
Are Investors Undervaluing Merck KGaA (ETR:MRK) By 29%?
Simply Wall St. via Yahoo Finance· 5 days agoSWOT Analysis for Merck KGaA Strength Debt is not viewed as a risk. Dividends are covered by...
Merck & Co. sees clear vision to new ophthalmology assets with $3B EyeBio buy
FierceBiotech· 2 days agoMerck & Co. is focusing in on eye diseases with the $3 billion acquisition of ophthalmology-focused Eyebiotech. Merck will take on a pipeline of vision ...
Health Care Roundup: Market Talk
The Wall Street Journal· 19 hours agoThe analysts forecast a margin expansion of 40 basis points in 2024-28, compared with market expectations 170 basis points. Innovation catalyzers for the...
AstraZeneca, Merck, GSK Struck Record $44.1B Licensing Deals With Chinese Drugmakers In 2023: Report...
Benzinga· 4 days agoWestern pharmaceutical companies and investors are driving a record number of licensing deals with...
Merck Announces Third-Quarter 2024 Dividend
Morningstar· 3 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.77 per share of ...
MSD agrees to acquire EyeBio for up to $3bn
Pharmaceutical Technology via Yahoo Finance· 1 day ago“As a subsidiary of Merck [MSD], EyeBio will be positioned to tap into the resources and infrastructure needed to support the clinical, regulatory and...
Ad
related to: merck pharmaceuticals
